Altogether, these data indicate that SPN and MUC1 modulate tumor cell sensitivity to CD20xCD3 bsAb independent of CD20 expression, while increased expression of CD52 directly affects CD20 cell surface levels. The gene discussed is MUC1; the disease is neoplasm.